The intensity of inflammation during COVID-19 is related to adverse outcomes. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is involved in… Read more PCSK9 inibition is tied with improved outcomes in severe COVID-19
Author: siriomedicine
Intracoronary epinephrine can significantly impact no-reflow in primary PCI after failure of other strategies: a novel effective therapy
The RESTORE-SIRIO study showed that as compared to use of conventional agents alone, Intracoronary epinephrine provides substantial improvement of coronary… Read more Intracoronary epinephrine can significantly impact no-reflow in primary PCI after failure of other strategies: a novel effective therapy
The lack of a mortality benefit may be associated with low baseline LDL-C levels
Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis. Navarese EP,… Read more The lack of a mortality benefit may be associated with low baseline LDL-C levels
ICD for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopaty
Implantable Cardioverter-Defibrillators for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopathy: A Systematic Review and Meta-analysis. Kolodziejczak M, Andreotti… Read more ICD for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopaty
Prevention of CIAKI in patients undergoing cardiovascular procedures – network meta-analysis
Prevention of contrast-induced acute kidney injury in patients undergoing cardiovascular procedures-a systematic review and network meta-analysis. Navarese EP, Gurbel PA,… Read more Prevention of CIAKI in patients undergoing cardiovascular procedures – network meta-analysis
The PCSK9-REACT study
Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study.… Read more The PCSK9-REACT study
PCSK9 antibodies for ACS: A Narrative Review
Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies for Acute Coronary Syndrome: A Narrative Review. Navarese EP, Kolodziejczak M, Kereiakes DJ,… Read more PCSK9 antibodies for ACS: A Narrative Review
PCSK9 antibodies: Critical considerations of mortality and neurocognitive findings
Role of PCSK9 antibodies in cardiovascular disease: Critical considerations of mortality and neurocognitive findings from the current literature. Kołodziejczak M,… Read more PCSK9 antibodies: Critical considerations of mortality and neurocognitive findings
From proprotein convertase subtilisin/kexin type 9 to its inhibition: state-of-the-art and clinical implications
From proprotein convertase subtilisin/kexin type 9 to its inhibition: state-of-the-art and clinical implications Navarese EP, Kołodziejczak M, Dimitroulis D, Wolff… Read more From proprotein convertase subtilisin/kexin type 9 to its inhibition: state-of-the-art and clinical implications
Anticoagulant strategies for ACS: network meta-analysis of 42 randomised trials involving 117,353 patients
Comparative efficacy and safety of anticoagulant strategies for acute coronary syndromes. Comprehensive network meta-analysis of 42 randomised trials involving 117,353… Read more Anticoagulant strategies for ACS: network meta-analysis of 42 randomised trials involving 117,353 patients
SIRIO MEDICINE 